Clinical Study

Risk And Protective Factors For Sga-Induced Metabolic Syndrome In Bipolar Youth

Posted Date: May 24, 2017

  • Investigator: Robert Mcnamara
  • Co-Investigator: Sireesha Pothukuchi
  • Specialties: Adolescent Psychiatry/Psychology, Psychiatry/Psychology, Bipolar Disorder
  • Type of Study: Drug

The first purpose of this study is to identify risk factors associated with developing cardiometabolic symptoms and weight gain after taking Quetiapine. Cardiometabolic risk refers to your chances of developing diabetes, elevated blood lipids, and h


Your Child Is Being Asked To Take Part In This Research Study Because He/She Is 10 To 17 Years Of Age (Inclusive) And Has Been Diagnosed With Bipolar Disorder, Type I, Manic Or Mixed Episode And Is Taking Or Is Not Taking Quetiapine.


Quetiapine, Adolescent, Bipolar, Seroquel, Omega 3

For More Information:

Lauren Miller

  • Search Clinical Studies

  • Research in the News

    Targeted Treatment Could Prevent Spread of Pancreatic Cancer, Heart Damage

    Researchers at the UC College of Medicine have shown that a new targetedtreatment could benefit patients with certain pancreatic tumors.